应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ALLO Allogene Therapeutics Inc.
休市中 07-11 16:00:00 EDT
1.28
+0.02
+1.59%
盘后
1.30
+0.02
+1.56%
19:42 EDT
最高
1.33
最低
1.26
成交量
290.74万
今开
1.29
昨收
1.26
日振幅
5.95%
总市值
2.80亿
流通市值
2.01亿
总股本
2.19亿
成交额
375.35万
换手率
1.85%
流通股本
1.57亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Allogene Therapeutics, Inc.盘中异动 快速跳水5.05%报1.04美元
市场透视 · 05-23
Allogene Therapeutics, Inc.盘中异动 快速跳水5.05%报1.04美元
币安:ALLO TGE活动的参与门槛为195币安Alpha积分
金色财经 · 05-22
币安:ALLO TGE活动的参与门槛为195币安Alpha积分
Allogene Therapeutics, Inc.盘中异动 下午盘股价大跌5.17%
市场透视 · 05-21
Allogene Therapeutics, Inc.盘中异动 下午盘股价大跌5.17%
Allogene Therapeutics, Inc.盘中异动 快速上涨5.05%报1.15美元
市场透视 · 05-20
Allogene Therapeutics, Inc.盘中异动 快速上涨5.05%报1.15美元
Allogene Therapeutics, Inc.2025财年第一财季实现净利润-59.73百万美元,同比增加8.11%
市场透视 · 05-18
Allogene Therapeutics, Inc.2025财年第一财季实现净利润-59.73百万美元,同比增加8.11%
Allogene Therapeutics, Inc.盘中异动 股价大涨5.99%
市场透视 · 05-15
Allogene Therapeutics, Inc.盘中异动 股价大涨5.99%
Piper Sandler:维持Allogene Therapeutics评级,由增持调整至增持评级, 目标价由9.00美元调整至7.00美元。
金融界 · 05-14
Piper Sandler:维持Allogene Therapeutics评级,由增持调整至增持评级, 目标价由9.00美元调整至7.00美元。
Allogene Therapeutics, Inc.盘中异动 早盘大幅下跌5.31%报1.07美元
市场透视 · 05-14
Allogene Therapeutics, Inc.盘中异动 早盘大幅下跌5.31%报1.07美元
Baird:维持Allogene Therapeutics(ALLO.US)评级,由优于大市调整至优于大市评级, 目标价由12.00美元调整至9.00美元。
金融界 · 05-14
Baird:维持Allogene Therapeutics(ALLO.US)评级,由优于大市调整至优于大市评级, 目标价由12.00美元调整至9.00美元。
Allogene Therapeutics, Inc.盘中异动 股价大跌5.00%报1.14美元
市场透视 · 05-08
Allogene Therapeutics, Inc.盘中异动 股价大跌5.00%报1.14美元
Allogene Therapeutics, Inc.盘中异动 急速跳水5.00%
市场透视 · 05-05
Allogene Therapeutics, Inc.盘中异动 急速跳水5.00%
Allogene Therapeutics, Inc.盘中异动 股价大涨5.03%
市场透视 · 05-02
Allogene Therapeutics, Inc.盘中异动 股价大涨5.03%
Allogene Therapeutics, Inc.盘中异动 快速跳水5.06%
市场透视 · 04-29
Allogene Therapeutics, Inc.盘中异动 快速跳水5.06%
Allogene Therapeutics, Inc.盘中异动 早盘股价大涨5.16%报1.63美元
市场透视 · 04-28
Allogene Therapeutics, Inc.盘中异动 早盘股价大涨5.16%报1.63美元
Allogene Therapeutics, Inc.盘中异动 早盘股价大涨5.35%报1.68美元
市场透视 · 04-23
Allogene Therapeutics, Inc.盘中异动 早盘股价大涨5.35%报1.68美元
Allogene Therapeutics, Inc.盘中异动 早盘股价大涨5.63%
市场透视 · 04-22
Allogene Therapeutics, Inc.盘中异动 早盘股价大涨5.63%
Allogene Therapeutics, Inc.盘中异动 股价大涨5.01%
市场透视 · 04-17
Allogene Therapeutics, Inc.盘中异动 股价大涨5.01%
Allogene Therapeutics, Inc.盘中异动 临近收盘大幅拉升5.11%报1.44美元
市场透视 · 04-11
Allogene Therapeutics, Inc.盘中异动 临近收盘大幅拉升5.11%报1.44美元
Allogene Therapeutics, Inc.盘中异动 股价大跌5.05%
市场透视 · 03-10
Allogene Therapeutics, Inc.盘中异动 股价大跌5.05%
Allogene Therapeutics, Inc.盘中异动 急速拉升5.18%
市场透视 · 03-06
Allogene Therapeutics, Inc.盘中异动 急速拉升5.18%
加载更多
公司概况
公司名称:
Allogene Therapeutics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Allogene Therapeutics, Inc.于2017年11月30日在特拉华州成立,总部位于加利福尼亚州南旧金山。该公司是一家临床阶段免疫肿瘤学公司,开创了用于治疗癌症的基因工程异体T细胞疗法的开发和商业化。公司正在开发一种现成的T细胞候选产品系列,旨在靶向和杀死癌细胞。Allogene Therapeutics, Inc.工程改造的T细胞是同种异体的,这意味着来自健康供体,用于任何患者,而不是来自患者的个体患者,如自体T细胞的情况。
发行价格:
--
{"stockData":{"symbol":"ALLO","market":"US","secType":"STK","nameCN":"Allogene Therapeutics Inc.","latestPrice":1.28,"timestamp":1752264000000,"preClose":1.26,"halted":0,"volume":2907374,"hourTrading":{"tag":"盘后","latestPrice":1.3,"preClose":1.28,"latestTime":"19:42 EDT","volume":51902,"amount":65889.6672,"timestamp":1752277360796},"delay":0,"floatShares":157188271,"shares":218730809,"eps":-1.222676,"marketStatus":"休市中","change":0.02,"latestTime":"07-11 16:00:00 EDT","open":1.29,"high":1.33,"low":1.255,"amount":3753536.7104348,"amplitude":0.059524,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.222676,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1539230400000,"exchange":"NASDAQ","adjPreClose":1.26,"preHourTrading":{"tag":"盘前","latestPrice":1.28,"preClose":1.26,"latestTime":"09:28 EDT","volume":4606,"amount":5894.2903698,"timestamp":1752240498346},"postHourTrading":{"tag":"盘后","latestPrice":1.3,"preClose":1.28,"latestTime":"19:42 EDT","volume":51902,"amount":65889.6672,"timestamp":1752277360796},"volumeRatio":0.586231,"impliedVol":2.067,"impliedVolPercentile":0.908},"requestUrl":"/m/hq/s/ALLO","defaultTab":"news","newsList":[{"id":"2537566491","title":"Allogene Therapeutics, Inc.盘中异动 快速跳水5.05%报1.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537566491","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537566491?lang=zh_cn&edition=full","pubTime":"2025-05-24 00:44","pubTimestamp":1748018661,"startTime":"0","endTime":"0","summary":"北京时间2025年05月24日00时44分,Allogene Therapeutics, Inc.股票出现波动,股价急速跳水5.05%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.36%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc 是一家临床阶段的生物技术公司,专门从事免疫肿瘤学,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体 T 细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052400442195009d54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052400442195009d54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","BK4505","ALLO","BK4539"],"gpt_icon":0},{"id":"2537995737","title":"币安:ALLO TGE活动的参与门槛为195币安Alpha积分","url":"https://stock-news.laohu8.com/highlight/detail?id=2537995737","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537995737?lang=zh_cn&edition=full","pubTime":"2025-05-22 13:50","pubTimestamp":1747893010,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://x.com/binancezh/status/1925428007566799181","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BK4505","ALLO","BK4139"],"gpt_icon":0},{"id":"2537953835","title":"Allogene Therapeutics, Inc.盘中异动 下午盘股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537953835","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537953835?lang=zh_cn&edition=full","pubTime":"2025-05-22 01:29","pubTimestamp":1747848557,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日01时29分,Allogene Therapeutics, Inc.股票出现异动,股价快速跳水5.17%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.25%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc 是一家临床阶段的生物技术公司,专门从事免疫肿瘤学,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体 T 细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522012918a6e7bbee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522012918a6e7bbee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLO","BK4539","LENZ","BK4007","BK4139","BK4505"],"gpt_icon":0},{"id":"2536643302","title":"Allogene Therapeutics, Inc.盘中异动 快速上涨5.05%报1.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536643302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536643302?lang=zh_cn&edition=full","pubTime":"2025-05-20 21:31","pubTimestamp":1747747897,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日21时31分,Allogene Therapeutics, Inc.股票出现异动,股价大幅拉升5.05%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.07%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc 是一家临床阶段的生物技术公司,专门从事免疫肿瘤学,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体 T 细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520213137aa2c93cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520213137aa2c93cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLO","BK4139","BK4505","BK4007","BK4539","LENZ"],"gpt_icon":0},{"id":"2536594111","title":"Allogene Therapeutics, Inc.2025财年第一财季实现净利润-59.73百万美元,同比增加8.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536594111","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536594111?lang=zh_cn&edition=full","pubTime":"2025-05-19 00:01","pubTimestamp":1747584109,"startTime":"0","endTime":"0","summary":"5月19日,Allogene Therapeutics, Inc.公布财报,公告显示公司2025财年第一财季净利润为-59.73百万美元,同比增加8.11%;其中营业收入为0.00美元,每股基本收益为-0.28美元。从资产负债表来看,Allogene Therapeutics, Inc.总负债1.23亿美元,其中短期债务7.63百万美元,资产负债比为4.14,流动比率为0.10。机构评级:截至2025年5月19日,当前有10家机构对Allogene Therapeutics, Inc.目标价做出预测,其中目标均价为8.20美元,其中最低目标价为3.00美元,最高目标价为14.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000704a482f1d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000704a482f1d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLO","LENZ"],"gpt_icon":0},{"id":"2535829733","title":"Allogene Therapeutics, Inc.盘中异动 股价大涨5.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535829733","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535829733?lang=zh_cn&edition=full","pubTime":"2025-05-15 21:58","pubTimestamp":1747317481,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日21时58分,Allogene Therapeutics, Inc.股票出现波动,股价大幅拉升5.99%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.44%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc 是一家临床阶段的生物技术公司,专门从事免疫肿瘤学,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体 T 细胞产品。消息层面,截至21时58分,《Piper Sandler:维持Allogene Therapeutics评级,由增持调整至增持评级, 目标价由9.00美元调整至7.00美元。》资讯为影响Allogene Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515215802aa2c8fe2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515215802aa2c8fe2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","ALLO","BK4505","BK4139","LENZ"],"gpt_icon":0},{"id":"2535777100","title":"Piper Sandler:维持Allogene Therapeutics评级,由增持调整至增持评级, 目标价由9.00美元调整至7.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535777100","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535777100?lang=zh_cn&edition=full","pubTime":"2025-05-15 00:15","pubTimestamp":1747239310,"startTime":"0","endTime":"0","summary":"Piper Sandler:维持Allogene Therapeutics(ALLO.US)评级,由增持调整至增持评级, 目标价由9.00美元调整至7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505150017599759a47d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505150017599759a47d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLO","LENZ"],"gpt_icon":0},{"id":"2535076325","title":"Allogene Therapeutics, Inc.盘中异动 早盘大幅下跌5.31%报1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535076325","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535076325?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:32","pubTimestamp":1747229525,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日21时32分,Allogene Therapeutics, Inc.股票出现波动,股价快速跳水5.31%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.12%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc 是一家临床阶段的生物技术公司,专门从事免疫肿瘤学,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体 T 细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514213206a6df08a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514213206a6df08a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4539","LENZ","BK4139","ALLO","BK4007"],"gpt_icon":0},{"id":"2535187027","title":"Baird:维持Allogene Therapeutics(ALLO.US)评级,由优于大市调整至优于大市评级, 目标价由12.00美元调整至9.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535187027","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535187027?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:28","pubTimestamp":1747229298,"startTime":"0","endTime":"0","summary":"Baird:维持Allogene Therapeutics(ALLO.US)评级,由优于大市调整至优于大市评级, 目标价由12.00美元调整至9.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/14212850393817.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","ALLO"],"gpt_icon":0},{"id":"2533310641","title":"Allogene Therapeutics, Inc.盘中异动 股价大跌5.00%报1.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533310641","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533310641?lang=zh_cn&edition=full","pubTime":"2025-05-08 21:56","pubTimestamp":1746712587,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日21时56分,Allogene Therapeutics, Inc.股票出现波动,股价快速跳水5.00%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为2.93%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc 是一家临床阶段的生物技术公司,专门从事免疫肿瘤学,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体 T 细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508215631a476d5da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508215631a476d5da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4505","BK4007","ALLO","BK4139"],"gpt_icon":0},{"id":"2533355742","title":"Allogene Therapeutics, Inc.盘中异动 急速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533355742","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533355742?lang=zh_cn&edition=full","pubTime":"2025-05-06 03:28","pubTimestamp":1746473310,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日03时28分,Allogene Therapeutics, Inc.股票出现波动,股价大幅下挫5.00%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.28%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc 是一家临床阶段的生物技术公司,专门从事免疫肿瘤学,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体 T 细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506032830a6d41c4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506032830a6d41c4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLO","BK4139","BK4007","BK4505","LENZ"],"gpt_icon":0},{"id":"2532182544","title":"Allogene Therapeutics, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532182544","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532182544?lang=zh_cn&edition=full","pubTime":"2025-05-02 21:34","pubTimestamp":1746192854,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日21时34分,Allogene Therapeutics, Inc.股票出现波动,股价快速拉升5.03%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.86%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc 是一家临床阶段的生物技术公司,专门从事免疫肿瘤学,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体 T 细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502213415aa2c81c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502213415aa2c81c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","BK4505","ALLO"],"gpt_icon":0},{"id":"2531957907","title":"Allogene Therapeutics, Inc.盘中异动 快速跳水5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531957907","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531957907?lang=zh_cn&edition=full","pubTime":"2025-04-30 03:41","pubTimestamp":1745955717,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日03时41分,Allogene Therapeutics, Inc.股票出现波动,股价快速跳水5.06%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.52%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc 是一家临床阶段的生物技术公司,专门从事免疫肿瘤学,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体 T 细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043003415794e7ee23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043003415794e7ee23&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4505","ALLO","BK4007","BK4139"],"gpt_icon":0},{"id":"2530282038","title":"Allogene Therapeutics, Inc.盘中异动 早盘股价大涨5.16%报1.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530282038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530282038?lang=zh_cn&edition=full","pubTime":"2025-04-28 22:15","pubTimestamp":1745849752,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日22时15分,Allogene Therapeutics, Inc.股票出现波动,股价急速上涨5.16%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.04%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc 是一家临床阶段的生物技术公司,专门从事免疫肿瘤学,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体 T 细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042822155294e60002&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042822155294e60002&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","ALLO","BK4139","BK4505"],"gpt_icon":0},{"id":"2529682977","title":"Allogene Therapeutics, Inc.盘中异动 早盘股价大涨5.35%报1.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529682977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529682977?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:30","pubTimestamp":1745415054,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时30分,Allogene Therapeutics, Inc.股票出现异动,股价大幅上涨5.35%。截至发稿,该股报1.68美元/股,成交量3.64万股,换手率0.02%,振幅0.00%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc 是一家临床阶段的生物技术公司,专门从事免疫肿瘤学,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体 T 细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213054a463f8e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213054a463f8e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ALLO","BK4505","BK4139","LENZ"],"gpt_icon":0},{"id":"2529582260","title":"Allogene Therapeutics, Inc.盘中异动 早盘股价大涨5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529582260","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529582260?lang=zh_cn&edition=full","pubTime":"2025-04-22 21:34","pubTimestamp":1745328882,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时34分,Allogene Therapeutics, Inc.股票出现异动,股价大幅拉升5.63%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.77%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc 是一家临床阶段的生物技术公司,专门从事免疫肿瘤学,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体 T 细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042221344394de3324&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042221344394de3324&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALLO","BK4007","BK4505","LENZ"],"gpt_icon":0},{"id":"2528532724","title":"Allogene Therapeutics, Inc.盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528532724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528532724?lang=zh_cn&edition=full","pubTime":"2025-04-18 01:40","pubTimestamp":1744911608,"startTime":"0","endTime":"0","summary":"北京时间2025年04月18日01时40分,Allogene Therapeutics, Inc.股票出现波动,股价大幅上涨5.01%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.66%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc 是一家临床阶段的生物技术公司,专门从事免疫肿瘤学,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体 T 细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418014008973b8620&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418014008973b8620&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALLO","BK4007","LENZ","BK4505"],"gpt_icon":0},{"id":"2526643479","title":"Allogene Therapeutics, Inc.盘中异动 临近收盘大幅拉升5.11%报1.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526643479","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526643479?lang=zh_cn&edition=full","pubTime":"2025-04-12 03:47","pubTimestamp":1744400841,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日03时47分,Allogene Therapeutics, Inc.股票出现异动,股价快速上涨5.11%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.88%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc 是一家临床阶段的生物技术公司,专门从事免疫肿瘤学,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体 T 细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412034723a456802b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412034723a456802b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4505","BK4139","LENZ","ALLO"],"gpt_icon":0},{"id":"2518320385","title":"Allogene Therapeutics, Inc.盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518320385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518320385?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:06","pubTimestamp":1741626373,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日01时06分,Allogene Therapeutics, Inc.股票出现异动,股价快速下挫5.05%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.59%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503110106139640612d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503110106139640612d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","ALLO","LENZ"],"gpt_icon":0},{"id":"2517192780","title":"Allogene Therapeutics, Inc.盘中异动 急速拉升5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517192780","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517192780?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:48","pubTimestamp":1741290532,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时48分,Allogene Therapeutics, Inc.股票出现异动,股价大幅上涨5.18%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.56%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307034853a262db6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307034853a262db6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","ALLO","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.allogene.com","stockEarnings":[{"period":"1week","weight":0.0588},{"period":"1month","weight":-0.137},{"period":"3month","weight":-0.131},{"period":"6month","weight":-0.3869},{"period":"1year","weight":-0.4728},{"period":"ytd","weight":-0.4085}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":0.0377},{"period":"3month","weight":0.1721},{"period":"6month","weight":0.0781},{"period":"1year","weight":0.1149},{"period":"ytd","weight":0.0678}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Allogene Therapeutics, Inc.于2017年11月30日在特拉华州成立,总部位于加利福尼亚州南旧金山。该公司是一家临床阶段免疫肿瘤学公司,开创了用于治疗癌症的基因工程异体T细胞疗法的开发和商业化。公司正在开发一种现成的T细胞候选产品系列,旨在靶向和杀死癌细胞。Allogene Therapeutics, Inc.工程改造的T细胞是同种异体的,这意味着来自健康供体,用于任何患者,而不是来自患者的个体患者,如自体T细胞的情况。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.039071},{"month":2,"riseRate":0.714286,"avgChangeRate":0.055444},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.131149},{"month":4,"riseRate":0.571429,"avgChangeRate":0.02606},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.015402},{"month":6,"riseRate":0.428571,"avgChangeRate":0.029943},{"month":7,"riseRate":0.571429,"avgChangeRate":0.052287},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.054633},{"month":9,"riseRate":0.666667,"avgChangeRate":-0.032739},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.102868},{"month":11,"riseRate":0.285714,"avgChangeRate":0.004346},{"month":12,"riseRate":0.142857,"avgChangeRate":-0.104939}],"exchange":"NASDAQ","name":"Allogene Therapeutics Inc.","nameEN":"Allogene Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Allogene Therapeutics Inc.(ALLO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Allogene Therapeutics Inc.(ALLO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Allogene Therapeutics Inc.,ALLO,Allogene Therapeutics Inc.股票,Allogene Therapeutics Inc.股票老虎,Allogene Therapeutics Inc.股票老虎国际,Allogene Therapeutics Inc.行情,Allogene Therapeutics Inc.股票行情,Allogene Therapeutics Inc.股价,Allogene Therapeutics Inc.股市,Allogene Therapeutics Inc.股票价格,Allogene Therapeutics Inc.股票交易,Allogene Therapeutics Inc.股票购买,Allogene Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Allogene Therapeutics Inc.(ALLO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Allogene Therapeutics Inc.(ALLO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}